Compare Crispr Therapeutics AG (CRSP) vs Progressive Corp (PGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Progressive Corp — how do they compare? Crispr Therapeutics AG trades at $53.88 (market cap $5.23B), while Progressive Corp trades at $211.9 (market cap $123.45B). The key difference: Progressive Corp is far larger — about 23.6× Crispr Therapeutics AG's market cap, and Progressive Corp pays a 6.55% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | PGR | |
|---|---|---|
Market Cap | $5.23B | $123.45B |
Sector | Health | Financials |
52-Week High | $76.78 | $252.68 |
52-Week Low | $44.34 | $190.40 |
Enterprise Value | $3.65B | $131.66B |
Dividend Yield | — | 6.55% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →
